Clinical presentation of prostate cancer in Black South Africans

Prostate

Volumn 74, Issue 8, 2014, Pages 880-891

  Tindall, Elizabeth A ^a   Richard Monare, L ^b   Petersen, Desiree C ^a,c   Van Zyl, Smit ^b   Hardie, Rae Anne ^c   Segone, Alpheus M ^b   Venter, Philip A ^b   Riana Bornman, M S ^d   Hayes, Vanessa M ^a,b,c,e,f  

^a J CRAIG VENTER INSTITUTE   (United States)

^b UNIVERSITY OF LIMPOPO   (South Africa)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e UNIVERSITY OF SYDNEY   (Australia)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

African ancestry; aggressive disease; clinical presentation; Prostate cancer; Southern Africa

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICAN; AGED; ARTICLE; BLACK PERSON; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE COURSE; GLEASON SCORE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RURAL AREA; SOCIAL STATUS; SOUTH AFRICA; URBAN AREA;

AFRICAN ANCESTRY; AGGRESSIVE DISEASE; CLINICAL PRESENTATION; PROSTATE CANCER; SOUTHERN AFRICA;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; COHORT STUDIES; FOLLOW-UP STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SOUTH AFRICA;

EID: 84899586724     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22806     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127 (12): 2893-2917.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61 (2): 69-90.
3. Delongchamps NB, Singh A, Haas GP,. Epidemiology of prostate cancer in Africa: Another step in the understanding of the disease ? Curr Probl Cancer 2007; 31 (3): 226-236.
4. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H, Part I,. Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 2008; 9 (7): 683-692.
5. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W,. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 2010; 183 (5): 1792-1796.
6. Peters N, Armstrong K,. Racial differences in prostate cancer treatment outcomes: A systematic review. Cancer Nurs 2005; 28 (2): 108-118.
7. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G,. The worldwide epidemiology of prostate cancer: Perspectives from autopsy studies. Can J Urol 2008; 15 (1): 3866-3871.
8. Bigler SA, Pound CR, Zhou X,. A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer 2011; 2011: 239460.
9. Chen YC, Page JH, Chen R, Giovannucci E,. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. Prostate 2008; 68 (14): 1582-1591.
10. Thomas JA, Gerber L, Moreira DM, Hamilton RJ, Bañez LL, Castro-Santamaria R, Andriole GL, Isaacs WB, Xu J, Freedland SJ,. Prostate cancer risk in men with prostate and breast cancer family history: Results from the REDUCE study (R1). J Intern Med 2012; 272 (1): 85-92.
11. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343 (2): 78-85.
12. Cnattingius S, Lundberg F, Sandin S, Grönberg H, Iliadou A,. Birth characteristics and risk of prostate cancer: The contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 2009; 18 (9): 2422-2426.
13. Martin DN, Starks AM, Ambs S,. Biological determinants of health disparities in prostate cancer. Curr Opin Oncol 2013; 25 (3): 235-241.
14. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N,. Prostate cancer disparities in Black men of African descent: A comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 2009; 4 (Suppl 1): S2.
15. Akinremi TO, Ogo CN, Olutunde AO,. Review of prostate cancer research in Nigeria. Infect Agent Cancer 2011; 6 (Suppl 2): S8.
16. Kabore FA, Zango B, Sanou A, Yameogo C, Kirakoya B,. Prostate cancer outcome in Burkina Faso. Infect Agent Cancer 2011; 6 (Suppl 2): S6.
17. Wasike RW, Magoha GA,. Descriptive case series of patients presenting with cancer of the prostate and their management at Kenyatta National Hospital, Nairobi. East Afr Med J 2007; 84 (9 Suppl): S31-S35.
18. Heyns CF, Fisher M, Lecuona A, van der Merwe A,. Prostate cancer among different racial groups in the Western Cape: Presenting features and management. S Afr Med J 2011; 101 (4): 267-270.
19. Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM,. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer 2013; 2013: 560857.
20. Henn BM, Cavalli-Sforza LL, Feldman MW,. The great human expansion. Proc Natl Acad Sci USA 2012; 109 (44): 17758-17764.
21. Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, Harris RS, Petersen DC, Zhao F, Qi J, Alkan C, Kidd JM, Sun Y, Drautz DI, Bouffard P, Muzny DM, Reid JG, Nazareth LV, Wang Q, Burhans R, Riemer C, Wittekindt NE, Moorjani P, Tindall EA, Danko CG, Teo WS, Buboltz AM, Zhang Z, Ma Q, Oosthuysen A, Steenkamp AW, Oostuisen H, Venter P, Gajewski J, Zhang Y, Pugh BF, Makova KD, Nekrutenko A, Mardis ER, Patterson N, Pringle TH, Chiaromonte F, Mullikin JC, Eichler EE, Hardison RC, Gibbs RA, Harkins TT, Hayes VM,. Complete Khoisan and Bantu genomes from southern Africa. Nature 2010; 463 (7283): 943-947.
22. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD,. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63 (6): 1839-1851.
23. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM,. The genetic structure and history of Africans and African Americans. Science 2009; 324 (5930): 1035-1044.
24. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM,. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63 (6): 963-966.
25. Lee J, Demissie K, Lu SE, Rhoads GG,. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 2007; 14 (1): 78-85.
26. Lehohla P,. Census2011 Census in brief, Statistics South Africa. In:, Africa SS, editor. Pretoria, South Africa: Statistics South Africa; 2012. p 105.
27. Tindall EA, Bornman MR, van Zyl S, Segone AM, Monare LR, Venter PA, Hayes VM,. Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa. BMC Urol 2013; 13: 74.
28. Henn BM, Gignoux CR, Jobin M, Granka JM, Macpherson JM, Kidd JM, Rodríguez-Botigué L, Ramachandran S, Hon L, Brisbin A, Lin AA, Underhill PA, Comas D, Kidd KK, Norman PJ, Parham P, Bustamante CD, Mountain JL, Feldman MW,. Hunter-gatherer genomic diversity suggests a southern African origin for modern humans. Proc Natl Acad Sci USA 2011; 108 (13): 5154-5162.
29. Pritchard JK, Stephens M, Donnelly P,. Inference of population structure using multilocus genotype data. Genetics 2000; 155 (2): 945-959.
30. Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, Lu-Yao GL,. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009; 101 (18): 1280-1283.
31. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA,. Prevalence of prostate cancer among men with a prostate-specific antigen level
32. Zakharia F, Basu A, Absher D, Assimes TL, Go AS, Hlatky MA, Iribarren C, Knowles JW, Li J, Narasimhan B, Sidney S, Southwick A, Myers RM, Quertermous T, Risch N, Tang H,. Characterizing the admixed African ancestry of African Americans. Genome Biol 2009; 10 (12): R141.
33. Diamond J, Bellwood P,. Farmers and their languages: The first expansions. Science 2003; 300 (5619): 597-603.
34. Newman JL,. The peopling of Africa: A geographic interpretation. USA: Yale University Press; 1995. 241 p.
35. Jalloh M, Friebel TM, Sira Thiam F, Niang L, Sy C, Siby T, Fernandez P, Mapulanga V, Maina Doodu S, Mante S, Yeboah E, Kyei M, Ankomah R, Amegbor J, Adusei B, Yegbe P, Watya S, Kaggwa S, Haiman C, Henderson BE, Narashimhamurthy M, Abuidris D, Mohamadani AA, Mohamed E, Mansoor MO, Elgaili EM, Elballal A, Zeigler-Johnson CM, Heyns CF, Gueye SM, Rebbeck TR,. Evaluation of 4,672 routine prostate biopsies performed in six African countries. J Afr Cancer 2013; 5 (3): 144-154.
36. Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y,. Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: The PROCESS cohort study. Br J Cancer 2010; 102 (2): 249-254.
37. Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT,. Volume-based referral for cancer surgery: Informing the debate. J Clin Oncol 2007; 25 (1): 91-96.